Stage zero cancer means abnormal cells that look like cancer under a microscope have been found, but they haven’t spread beyond the exact spot where they started. These cells remain confined to the surface layer of tissue and have not pushed through a critical boundary called the basement membrane, a thin barrier separating surface cells from deeper tissue. Because nothing has spread, stage zero has an extremely high survival rate and is often curable with minimal treatment.
The medical term for this condition is carcinoma in situ, which literally translates to “cancer in place.” It sits in an unusual gray zone: the cells are abnormal enough to be classified within cancer staging, but they haven’t yet behaved like a true invasive cancer.
How Stage Zero Fits Into Cancer Staging
Doctors classify cancers using the TNM system, which evaluates three things: the size and depth of the primary tumor (T), whether cancer has reached nearby lymph nodes (N), and whether it has spread to distant parts of the body (M). Stage zero is classified as Tis, N0, M0. That shorthand means the abnormal cells are in situ (still in their original location), no lymph nodes are involved, and there’s no spread anywhere else.
Stages go from 0 through IV, with higher numbers indicating more extensive spread. Stage zero is the earliest possible point on this spectrum. Not every type of cancer has a stage zero form, but several common ones do, including breast, skin, bladder, and colorectal cancers.
Where Stage Zero Cancer Is Most Common
Breast (DCIS)
Ductal carcinoma in situ, or DCIS, is stage zero breast cancer. Abnormal cells line the inside of a milk duct but haven’t broken through the duct wall into surrounding breast tissue. DCIS is almost always detected on a mammogram, often showing up as tiny clusters of calcium deposits called microcalcifications before any lump can be felt. For localized breast cancers including stage zero, the five-year relative survival rate is 99.6%.
Treatment typically involves a lumpectomy, which removes the affected area plus a small margin of healthy tissue around it. Radiation therapy often follows to reduce the chance of recurrence or progression. If the DCIS is hormone-sensitive, meaning it uses estrogen or progesterone to fuel growth, hormone-blocking medication may also be recommended. In some cases, a mastectomy is considered, though many women with DCIS are treated successfully with breast-conserving surgery alone.
Skin (Melanoma in Situ)
Stage zero melanoma means the abnormal cells are confined entirely to the epidermis, the outermost layer of skin. They haven’t reached the deeper dermis layer where blood vessels and lymph channels could carry cells elsewhere. Treatment is straightforward: a dermatologist removes the melanoma along with a margin of normal skin around it, usually under local anesthesia in an office setting. The amount of surrounding skin removed depends on the size and location of the lesion.
Colorectal
In the colon or rectum, stage zero cancer develops when abnormal cells within a polyp remain confined to the inner lining of the intestinal wall without penetrating into the deeper muscular layers. This is a meaningful distinction: once cells push through into the submucosa (the layer just beneath the lining), the polyp is reclassified as stage I and gains the ability to spread to lymph nodes or distant sites.
Most stage zero colorectal lesions are cured simply by removing the polyp during a colonoscopy, a procedure called polypectomy. Research tracking nearly 6,000 patients with stage zero colorectal cancer found a five-year recurrence rate of just 1.68% and a five-year cancer-specific mortality rate of 0.6%. However, about 1.6% of these patients were found to have lymph node involvement on closer surgical examination, which is why follow-up monitoring matters even after a seemingly complete removal.
Bladder
Stage zero bladder cancer comes in two forms. Stage 0a appears as thin, finger-like growths projecting into the interior of the bladder. These papillary tumors can be low-grade or high-grade. Stage 0is is a flat tumor sitting on the bladder lining and is always high-grade, meaning the cells look more abnormal and carry a higher risk of eventually becoming invasive.
Bladder cancer has a notable tendency to recur even when caught at stage zero. Low-grade tumors usually come back in the bladder lining, while high-grade tumors are more likely to progress into the muscle wall on recurrence. This is why bladder cancer patients typically undergo regular surveillance with cystoscopy (a camera exam of the bladder) for years after treatment.
How Stage Zero Cancer Is Found
Because stage zero cancer hasn’t spread and rarely causes symptoms, it’s almost always caught through routine screening. Mammography is the primary tool for finding DCIS, with sensitivity ranging from 71% to 96% depending on factors like breast density and patient age. For women with denser breast tissue, ultrasound serves as a valuable supplemental tool. Colorectal stage zero lesions are found during screening colonoscopies. Melanoma in situ is usually spotted during a skin exam by a dermatologist.
A biopsy is always required to confirm the diagnosis. Imaging can raise suspicion, but only a pathologist looking at cells under a microscope can determine whether they meet the criteria for carcinoma in situ versus a benign abnormality.
Can Stage Zero Progress to Invasive Cancer?
Yes, but not always, and this uncertainty is one of the most active debates in cancer care. Some stage zero lesions will eventually break through the basement membrane and become invasive cancers. Others will remain dormant for a person’s entire lifetime and never cause harm. The challenge is that doctors can’t always predict which path a given lesion will take.
This unpredictability has raised concerns about overtreatment, particularly for DCIS. Estimates suggest that up to 80% of DCIS lesions are indolent, meaning they would never progress to invasive breast cancer during a patient’s lifetime. Clinical trials are now studying whether active surveillance, which involves close monitoring with regular imaging instead of immediate surgery, is a safe option for women with low-risk DCIS. In one trial, 76% of eligible women chose active surveillance over conventional treatment, most commonly because they felt treatment wasn’t yet necessary and trusted the monitoring plan.
For other types, like high-grade bladder carcinoma in situ, the risk of progression is higher, and treatment is generally recommended promptly. The decision depends heavily on the specific cancer type, the grade of the abnormal cells, and individual risk factors.
What Recovery and Follow-Up Look Like
Because stage zero treatment is typically limited to removing a small area of tissue, recovery is relatively quick compared to treatment for invasive cancers. A lumpectomy or skin excision usually involves a few weeks of healing. Polypectomy during colonoscopy often requires no downtime at all.
The more significant commitment is long-term monitoring. Most people treated for stage zero cancer will have a schedule of follow-up imaging or exams for several years afterward. For breast cancer, this means regular mammograms. For colorectal cancer, repeat colonoscopies at set intervals. For bladder cancer, periodic cystoscopy. These follow-ups are designed to catch any recurrence early, while it’s still highly treatable.